Corollary to such a mechanism, inhibitors of Ang II formation, agents that increase metabolism of Ang II, and AT1 receptor blockers that lower BP may decrease tumor growth by disproportionately reducing blood flow to the tumor. The gene discussed is AGTR1; the disease is neoplasm.